Glaucoma management: relative value and place in therapy of available drug treatments.
about
The Suprachoroidal Route in Glaucoma SurgeryDevelopment of a Δ9-Tetrahydrocannabinol Amino Acid-Dicarboxylate Prodrug With Improved Ocular Bioavailability.Patient satisfaction with fixed-combination bimatoprost/timolol ophthalmic solution: a survey study in patients with glaucoma in China.Efficacy and safety of benzalkonium chloride-free fixed-dose combination of latanoprost and timolol in patients with open-angle glaucoma or ocular hypertension.Excipients of preservative-free latanoprost induced inflammatory response and cytotoxicity in immortalized human HCE-2 corneal epithelial cells.Pharmacotherapy of glaucoma.Latanoprostene bunod ophthalmic solution 0.024% for IOP lowering in glaucoma and ocular hypertension.Emerging drugs to treat glaucoma: targeting prostaglandin F and E receptors.Human TBK1: A Gatekeeper of NeuroinflammationInvestigational and experimental drugs for intraocular pressure reduction in ocular hypertension and glaucoma.Rodent models of glaucoma and their applicability for drug discovery.Brimonidine and brinzolamide for treating glaucoma and ocular hypertension; a safety evaluation.Tyrosine triple mutated AAV2-BDNF gene therapy in a rat model of transient IOP elevation.Human Pluripotent Stem Cell-Derived Retinal Ganglion Cells: Applications for the Study and Treatment of Optic Neuropathies.Hydrus microstent compared to selective laser trabeculoplasty in primary open angle glaucoma: one year results.gem-Dinitroalkyl Benzenes: A Novel Class of IOP-Lowering Agents for the Treatment of Ocular Hypertension.Agonistic Autoantibodies to the β2-Adrenergic Receptor Involved in the Pathogenesis of Open-Angle Glaucoma.Profile of netarsudil ophthalmic solution and its potential in the treatment of open-angle glaucoma: evidence to date
P2860
Q26745651-CEEAF488-1537-4D11-B968-0C78B46223DBQ33558455-560278C9-BBD1-4750-B9F6-F8D622F0E599Q33638121-A43BE02D-FF3B-424B-A278-876DF8A4D2FAQ33857744-4B375ECA-F78C-4D27-B6D2-FEA2BF07C98BQ34730252-8F95838E-0E8E-4896-9205-5710F28CD984Q35138049-3D447C09-7EC9-4A42-A85A-3309F2F500DCQ38405486-00456330-46C1-44D1-A287-8576D43BA41FQ38725839-2D9974C2-2915-4576-A143-A371C9DCC49AQ38841234-1C4741B4-65D2-45C9-B076-6B6C9EDB6BC2Q38934012-6B743568-3A33-432E-85B0-8FA36E8285AFQ39079602-8422849B-0C08-4215-A0F5-252B214CD804Q39401937-7FE836FF-31DB-4631-B7D4-D64907EC022DQ40640361-0CA40AC5-1496-439C-AC93-23343F36BBA9Q42099855-228E1910-9FC8-4A70-AC6F-89893227A5B3Q47734505-3634C3D3-6A4A-470A-852B-E9596BD7F9A6Q50066089-365FA6C3-5299-4BE5-84EF-3F9BD71666E2Q51747222-D3A022E6-2B0A-488D-A5DA-9E06371C57D2Q57483560-8472C1CD-0CBD-4254-8A88-F251A664D560
P2860
Glaucoma management: relative value and place in therapy of available drug treatments.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Glaucoma management: relative value and place in therapy of available drug treatments.
@ast
Glaucoma management: relative value and place in therapy of available drug treatments.
@en
type
label
Glaucoma management: relative value and place in therapy of available drug treatments.
@ast
Glaucoma management: relative value and place in therapy of available drug treatments.
@en
prefLabel
Glaucoma management: relative value and place in therapy of available drug treatments.
@ast
Glaucoma management: relative value and place in therapy of available drug treatments.
@en
P2860
P356
P1476
Glaucoma management: relative value and place in therapy of available drug treatments.
@en
P2093
Ahmad A Aref
Deepak Sambhara
P2860
P356
10.1177/2040622313511286
P577
2014-01-01T00:00:00Z